Bicycle Therapeutics Ltd
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.1% | +0.2% | -0.9% | +32.2% | -22.2% | -2.8% | +3.4% | +3.5% | -390.0% | – | -5.5% | – | |
| – | +5.1% | +18.8% | -0.2% | -0.7% | +12.3% | -7.0% | -1.8% | -7.0% | -417.1% | – | -7.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -125.1% | – | – | – | +5,592.7% | -199.3% | – | – | – | -120.5% | – | – | |
| – | -89.8% | -76.5% | +3,403.2% | +3.5% | -15.4% | +64.8% | -17.9% | +35.3% | +163.8% | -59.9% | -62.8% | – | |
| – | -89.8% | -76.5% | +3,403.2% | +3.5% | -15.4% | +64.8% | -17.9% | +35.3% | -15.2% | +24.7% | -62.8% | – | |
| – | – | – | – | – | -99.9% | +2.4% | +7.0% | -32.6% | +54.8% | +37.5% | -22.7% | – | |
| – | -99.8% | +384.4% | +29,301.1% | -105.8% | – | -120.3% | +9.3% | -33.3% | -50.5% | +263.8% | -7.4% | – | |
| – | -119.7% | – | – | -114.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.